Post by Helix Biogen Institute

🚀 𝗛𝗲𝗹𝗶𝘅 𝗕𝗶𝗼𝗴𝗲𝗻 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗝𝗼𝗶𝗻𝘀 𝗦𝗖𝗗𝗔𝗦𝗦 𝟮𝟬𝟮𝟲 𝗮𝘀 𝗮𝗻 𝗢𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 We are delighted to announce that Helix Biogen Institute is an official partner of the Sickle Cell Disease African Scientific Symposium (SCDASS 2026), organized by Xcene Research. This partnership reflects our shared commitment to advancing scientific innovation, strengthening research collaboration, and accelerating drug discovery and development efforts aimed at addressing the burden of Sickle Cell Disease across Africa. At Helix Biogen Institute, we believe that transformative healthcare solutions emerge when researchers, clinicians, industry leaders, policymakers, and innovators come together to tackle complex health challenges. SCDASS 2026 provides an important platform to foster these collaborations and drive meaningful impact for patients and communities. 📍 Venue: Marriott Hotel, Ikeja, Lagos, Nigeria 📅 Date: July 30–31, 2026 We look forward to engaging with leading experts and stakeholders from across the continent as we collectively shape the future of Sickle Cell Disease research, treatment, and care in Africa. We thank Xcene Research for this opportunity and look forward to a successful and impactful symposium. Dr. Oladipo Elijah Kolawole (Ph.D) Oluwaseyi Akinpelu Goodness Umunakwe James Ogunniran Jesulayomi Babarinde Mercy Faleyimu Oluwaseun Aremu Nigerian Institute of Medical Research (NIMR) University of Lagos #SCDASS2026 #HelixBiogenInstitute #SickleCellDisease #DrugDiscovery #ClinicalResearch #BiomedicalResearch #HealthcareInnovation #AfricanResearch #PrecisionMedicine #TranslationalResearch #PartnershipsForImpact